| Title |
Role of berberine in Alzheimer’s disease
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, October 2016
|
| DOI | 10.2147/ndt.s114846 |
| Pubmed ID | |
| Authors |
Zhiyou Cai, Chuanling Wang, Wenming Yang |
X Demographics
The data shown below were collected from the profiles of 67 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 19 | 28% |
| Canada | 6 | 9% |
| Azerbaijan | 1 | 1% |
| India | 1 | 1% |
| Germany | 1 | 1% |
| Australia | 1 | 1% |
| Central African Republic | 1 | 1% |
| United Kingdom | 1 | 1% |
| Unknown | 36 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 55 | 82% |
| Practitioners (doctors, other healthcare professionals) | 5 | 7% |
| Scientists | 5 | 7% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Unknown | 151 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 13% |
| Student > Ph. D. Student | 18 | 12% |
| Researcher | 14 | 9% |
| Student > Bachelor | 12 | 8% |
| Student > Doctoral Student | 7 | 5% |
| Other | 28 | 18% |
| Unknown | 54 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 13% |
| Biochemistry, Genetics and Molecular Biology | 18 | 12% |
| Neuroscience | 12 | 8% |
| Medicine and Dentistry | 8 | 5% |
| Chemistry | 7 | 5% |
| Other | 17 | 11% |
| Unknown | 71 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#777,535
of 25,807,758 outputs
Outputs from Neuropsychiatric Disease and Treatment
#96
of 3,150 outputs
Outputs of similar age
#14,590
of 333,963 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 85 outputs
Altmetric has tracked 25,807,758 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,150 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.